3 results
Approved WMOCompleted
The aim of the study is to confirm efficacy and safety of treatment with 600 mg of BID BI207127 in combination with 120 mg QD Faldaprevir and RBV for 16 and 24 weeks in target chronically infected HCV GT1b treatment naïve patients, including a…
Approved WMOPending
Primary Objective: to study the feasibility, effectiveness and user experience of the Parkinson smartwatch in Parkinson patients with response fluctuations (with dyskinesia).Secondary Objective(s): to study the effect on cost, by monitoring the…
Approved WMOPending
The primary objective is to evaluate the EndoRotor®*s ability to safely remove non-viable/necrotic tissue for direct endoscopic necrosectomy in patients with walled off pancreatic necrosis